Saturday 17 October 2026 Export AXSM’s income statement to Excel — free account

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024. In the quarter to June 2026, revenue grew 45.5%, EPS fell 2.06%, free cash flow fell 2.98% and total debt rose 4.66%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

157.14 4.65 −2.87%

Follow AXSM

Alert me

Market cap: $8.5B
P/E: 0.0×
Fwd P/E: −121×
Dividend yield: —
F-score: 5/9
Altman Z: 6.91
Beneish M: −2.53
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	16.33	12.22	14.23	10.82
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(384.77)	(418.04)	(487.10)	5,808.00
P/B ratio Full definition →	152.20	158.53	102.90	82.40
Price to Tangible BV Full definition →	373.97	2,405.15	254.26	310.61
EV/Sales Full definition →	16.08	11.96	13.92	10.46
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(175.23)	(119.79)	(95.13)	(58.17)
EV/FCF Full definition →	(173.53)	(119.35)	(94.64)	(57.92)
Quick Ratio Full definition →	1.30	1.27	1.44	1.45
Current Ratio Full definition →	1.43	1.39	1.55	1.57
Net Debt/EBITDA Full definition →	4.14	2.98	8.20	4.66
Debt/Assets Full definition →	16.68%	17.33%	17.68%	18.28%
Debt/Equity Full definition →	1.52	2.27	1.38	1.66
Asset Turnover Full definition →	1.11	1.08	1.01	0.91
Operating CF/Net income Full definition →	0.64	0.32	0.65	(0.02)
Capex/Depreciation Full definition →	(0.15)	(0.05)	(0.03)	(0.02)
Interest Coverage Full definition →	(32.24)	(53.47)	(23.00)	(41.17)
Research and Development Expense of Revenue Full definition →	21.17%	27.55%	24.89%	23.49%
Selling, General and Administrative Expense of Revenue Full definition →	95.31%	96.75%	86.38%	87.86%
Intangible Assets out of Total Assets Full definition →	0.06	0.07	0.08	0.08
Share Based Compensation of Revenue Full definition →	12.43%	12.26%	11.60%	13.51%
Graham Net Nets Full definition →	0.00	(0.01)	0.00	0.00
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(1.53%)	(2.21%)	(2.02%)	(3.85%)
Free Cash Flow Yield Full definition →	(0.57%)	(0.82%)	(1.03%)	(1.67%)
Revenue per Share Full definition →	4.22	3.73	3.94	3.42
Operating CF per Share Full definition →	(0.64)	(0.40)	(0.37)	0.02
Capex per Share Full definition →	(0.01)	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.64)	(0.41)	(0.38)	0.02
Cash per Share Full definition →	6.17	5.96	6.49	6.50
Shareholders Equity per Share Full definition →	1.61	1.07	1.77	1.47
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.61	1.07	1.77	1.47
Free Cash Flow Full definition →	(33.40)	(20.82)	(18.72)	0.99
Working Capital Full definition →	196.12	172.00	210.15	205.05
Capital Expenditures Full definition →	(0.45)	(0.12)	(0.07)	(0.06)
Net Current Asset Value Full definition →	(21.57)	(47.81)	(12.52)	(30.18)
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	238.14	206.23	183.23	160.30
Average Payables Full definition →	85.30	96.18	68.77	59.24
Average Inventory Full definition →	28.16	23.92	21.84	19.02
Average Assets Full definition →	700.62	655.14	629.15	615.35
Average Common Equity Full definition →	78.19	53.90	72.65	83.31

Fold the line items

Columns are period end dates

Stockrow Weekly